The VEGF rise in blood of bevacizumab patients is not based on tumor escape but a host-blockade of VEGF clearance.

Lejla Alidzanovic; Patrick Starlinger; Dominic Schauer; Thomas Maier; Alexandra Feldman; Elisabeth Buchberger; Judith Stift; Ulrike Koeck; Lorand Pop; Birgit Gruenberger; Thomas Gruenberger; Christine Brostjan

doi:10.18632/oncotarget.11084

The VEGF rise in blood of bevacizumab patients is not based on tumor escape but a host-blockade of VEGF clearance.

Lejla Alidzanovic, Patrick Starlinger, Dominic Schauer, Thomas Maier, Alexandra Feldman, Elisabeth Buchberger, Judith Stift, Ulrike Koeck, Lorand Pop, Birgit Gruenberger, Thomas Gruenberger, Christine Brostjan

Department of Internal Medicine I- Division of Gastroenterology, Hepatology, Nephrology, Metabolism and Diabetologylog

Research output: Contribution to journal › Original Article › peer-review

37 Citations (Web of Science)

Original language	English
Pages (from-to)	5719-57212
Journal	Oncotarget
Volume	7
Issue number	35
DOIs	https://doi.org/10.18632/oncotarget.11084
Publication status	Published - 2016

Keywords

ENDOTHELIAL GROWTH-FACTOR
METASTATIC COLORECTAL-CANCER
HUMAN COLON-CANCER
ANTIANGIOGENIC THERAPY
LIVER METASTASES
ANGIOGENESIS
EXPRESSION
RECEPTOR
PLASMA
CELLS

Access to Document

10.18632/oncotarget.11084

Cite this

@article{87bcb72e5cd046c39c6f4d0468710cbf,

title = "The VEGF rise in blood of bevacizumab patients is not based on tumor escape but a host-blockade of VEGF clearance.",

keywords = "ENDOTHELIAL GROWTH-FACTOR, METASTATIC COLORECTAL-CANCER, HUMAN COLON-CANCER, ANTIANGIOGENIC THERAPY, LIVER METASTASES, ANGIOGENESIS, EXPRESSION, RECEPTOR, PLASMA, CELLS",

author = "Lejla Alidzanovic and Patrick Starlinger and Dominic Schauer and Thomas Maier and Alexandra Feldman and Elisabeth Buchberger and Judith Stift and Ulrike Koeck and Lorand Pop and Birgit Gruenberger and Thomas Gruenberger and Christine Brostjan",

year = "2016",

doi = "10.18632/oncotarget.11084",

language = "English",

volume = "7",

pages = "5719--57212",

journal = "Oncotarget",

issn = "1949-2553",

number = "35",

}

TY - JOUR

T1 - The VEGF rise in blood of bevacizumab patients is not based on tumor escape but a host-blockade of VEGF clearance.

AU - Alidzanovic, Lejla

AU - Starlinger, Patrick

AU - Schauer, Dominic

AU - Maier, Thomas

AU - Feldman, Alexandra

AU - Buchberger, Elisabeth

AU - Stift, Judith

AU - Koeck, Ulrike

AU - Pop, Lorand

AU - Gruenberger, Birgit

AU - Gruenberger, Thomas

AU - Brostjan, Christine

PY - 2016

Y1 - 2016

KW - ENDOTHELIAL GROWTH-FACTOR

KW - METASTATIC COLORECTAL-CANCER

KW - HUMAN COLON-CANCER

KW - ANTIANGIOGENIC THERAPY

KW - LIVER METASTASES

KW - ANGIOGENESIS

KW - EXPRESSION

KW - RECEPTOR

KW - PLASMA

KW - CELLS

U2 - 10.18632/oncotarget.11084

DO - 10.18632/oncotarget.11084

M3 - Original Article

C2 - 27527865

SN - 1949-2553

VL - 7

SP - 5719

EP - 57212

JO - Oncotarget

JF - Oncotarget

IS - 35

ER -